Muscleblind acts as a modifier of FUS toxicity by modulating stress granule dynamics and SMN localization

Mutations in fused in sarcoma (FUS) lead to amyotrophic lateral sclerosis (ALS) with varying ages of onset, progression and severity. This suggests that unknown genetic factors contribute to disease pathogenesis. Here we show the identification of muscleblind as a novel modifier of FUS-mediated neur...

Descripción completa

Detalles Bibliográficos
Autores principales: Casci, Ian, Krishnamurthy, Karthik, Kour, Sukhleen, Tripathy, Vadreenath, Ramesh, Nandini, Anderson, Eric N., Marrone, Lara, Grant, Rogan A., Oliver, Stacie, Gochenaur, Lauren, Patel, Krishani, Sterneckert, Jared, Gleixner, Amanda M., Donnelly, Christopher J., Ruepp, Marc-David, Sini, Antonella M., Zuccaro, Emanuela, Pennuto, Maria, Pasinelli, Piera, Pandey, Udai Bhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898697/
https://www.ncbi.nlm.nih.gov/pubmed/31811140
http://dx.doi.org/10.1038/s41467-019-13383-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898697/
https://www.ncbi.nlm.nih.gov/pubmed/31811140
http://dx.doi.org/10.1038/s41467-019-13383-z

Ejemplares similares